Loading...

We've got a brand new version of Simply Wall St! Try it out

Dixie Brands

CNSX:DIXI.U
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
DIXI.U
CNSX
$70M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Dixie Brands Inc., through its subsidiaries, provides marijuana infused products. The last earnings update was 24 days ago. More info.


Add to Portfolio Compare Print
  • Dixie Brands has significant price volatility in the past 3 months.
DIXI.U Share Price and Events
7 Day Returns
12%
CNSX:DIXI.U
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-
CNSX:DIXI.U
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
DIXI.U Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Dixie Brands (DIXI.U) 12% -18.8% -15.2% - - -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • No trading data on DIXI.U.
  • No trading data on DIXI.U.
Price Volatility
Industry
5yr Volatility vs Market

DIXI.U Value

 Is Dixie Brands undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Dixie Brands. This is due to cash flow or dividend data being unavailable. The share price is $0.56.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Dixie Brands's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Dixie Brands's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:DIXI.U PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.32
CNSX:DIXI.U Share Price ** CNSX (2019-09-20) in USD $0.56
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Dixie Brands.

CNSX:DIXI.U PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:DIXI.U Share Price ÷ EPS (both in USD)

= 0.56 ÷ -0.32

-1.72x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dixie Brands is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Dixie Brands is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Dixie Brands's expected growth come at a high price?
Raw Data
CNSX:DIXI.U PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.72x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Dixie Brands, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Dixie Brands's assets?
Raw Data
CNSX:DIXI.U PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $0.01
CNSX:DIXI.U Share Price * CNSX (2019-09-20) in USD $0.56
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:DIXI.U PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:DIXI.U Share Price ÷ Book Value per Share (both in USD)

= 0.56 ÷ 0.01

38.27x

* Primary Listing of Dixie Brands.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dixie Brands is overvalued based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Dixie Brands's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Dixie Brands has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

DIXI.U Future Performance

 How is Dixie Brands expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dixie Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
97.7%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Dixie Brands expected to grow at an attractive rate?
  • Unable to compare Dixie Brands's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Dixie Brands's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Dixie Brands's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:DIXI.U Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:DIXI.U Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:DIXI.U Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 9 -14 -32
2019-03-31 7 -10 -26
2018-12-31 6 -3 -20
2018-09-30 5 -2 -7
2018-06-30 4 0 -5
2018-03-31 4 -2 -4
2017-12-31 3 -3 -4
2016-12-31 2 -2 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Dixie Brands is high growth as no earnings estimate data is available.
  • Unable to determine if Dixie Brands is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:DIXI.U Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Dixie Brands Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:DIXI.U Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.32
2019-03-31 -0.33
2018-12-31 -0.35
2018-09-30 -1.66
2018-06-30 -1.14
2018-03-31 -0.09
2017-12-31 -0.09
2016-12-31 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Dixie Brands will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of DIXI.U’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Dixie Brands's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Dixie Brands's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Dixie Brands's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Dixie Brands has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

DIXI.U Past Performance

  How has Dixie Brands performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Dixie Brands's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Dixie Brands does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Dixie Brands's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Dixie Brands's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Dixie Brands's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Dixie Brands Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:DIXI.U Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 9.25 -31.66 28.12
2019-03-31 7.07 -26.08 22.64
2018-12-31 5.79 -20.29 15.93
2018-09-30 4.91 -6.69 5.75
2018-06-30 3.63 -4.58 4.89
2018-03-31 3.55 -4.12 4.03
2017-12-31 3.34 -4.04 4.08
2016-12-31 2.38 -4.03 3.99

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Dixie Brands has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Dixie Brands has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Dixie Brands improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Dixie Brands's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Dixie Brands has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

DIXI.U Health

 How is Dixie Brands's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Dixie Brands's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Dixie Brands's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Dixie Brands's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Dixie Brands's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are -205.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Dixie Brands Company Filings, last reported 2 months ago.

CNSX:DIXI.U Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 0.35 0.00 2.28
2019-03-31 4.78 0.00 5.64
2018-12-31 15.94 0.78 18.36
2018-09-30 20.93 0.93 18.58
2018-06-30 -0.16 3.91 2.36
2018-03-31 -2.21 6.17 0.04
2017-12-31 -2.21 6.11 0.04
2016-12-31 2.03 2.49 0.82
  • Unable to establish if Dixie Brands's level of debt is high without past debt data.
  • Unable to establish if Dixie Brands's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Dixie Brands has less than a year of cash runway based on current free cash flow.
  • Dixie Brands has less than a year of cash runway if free cash flow continues to grow at historical rates of 71.8% each year.
X
Financial health checks
We assess Dixie Brands's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Dixie Brands has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

DIXI.U Dividends

 What is Dixie Brands's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Dixie Brands dividends.
If you bought $2,000 of Dixie Brands shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Dixie Brands's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Dixie Brands's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:DIXI.U Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Dixie Brands has not reported any payouts.
  • Unable to verify if Dixie Brands's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Dixie Brands's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Dixie Brands has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Dixie Brands's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Dixie Brands afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Dixie Brands has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

DIXI.U Management

 What is the CEO of Dixie Brands's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Chuck Smith
COMPENSATION $456,730
AGE 58
CEO Bio

Mr. Charles Smith, also known as Chuck, serves as Chief Executive Officer, President and Director at Dixie Brands, Inc. and served as its Chief Operating Officer of Dixie Brands, Inc. Mr. Smith is also one of the original founders of the Dixie Elixirs and Edibles Company in 2009. Mr. Smith serves as the President of Bella Terra Realty Holdings since 2007. Mr. Smith served as the President of Sagebrush Realty Development from 2005 to 2007. Mr. Smith has experience in a variety of industries. He has a strong financial background, holding the position of Chief Financial Officer for a mid-sized retail apparel chain, has built and managed sales and marketing teams for private and publicly traded technology companies and has successfully founded two companies, including one in the alcohol beverage industry. He has been a Director of CSA Holdings Inc. since September 04, 2015. He serves as a Director at Dixie Brands, Inc. since November 27, 2018. Mr. Smith has a Bachelor's degree in Accounting from the University of Maryland and an MBA from the Owen Graduate School at Vanderbilt University.

CEO Compensation
  • Insufficient data for Chuck to compare compensation growth.
  • Chuck's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Dixie Brands management team in years:

0.7
Average Tenure
  • The average tenure for the Dixie Brands management team is less than 2 years, this suggests a new team.
Management Team

Chuck Smith

TITLE
President
COMPENSATION
$457K
AGE
58

Combus Chapman

TITLE
General Counsel & Secretary
COMPENSATION
$165K

Greg Robbins

TITLE
Chief Financial Officer
TENURE
0.3 yrs

Andrew Floor

TITLE
Vice President of Marketing
TENURE
0.7 yrs

Oliver Arnold

TITLE
Vice President of Sales
TENURE
0.7 yrs

Bob Rubin

TITLE
President of Therabis
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure and age of the Dixie Brands board of directors in years:

0.8
Average Tenure
58
Average Age
  • The average tenure for the Dixie Brands board of directors is less than 3 years, this suggests a new board.
Board of Directors

Chuck Smith

TITLE
President
COMPENSATION
$457K
AGE
58
TENURE
0.8 yrs

Tripp Keber

TITLE
Director
COMPENSATION
$350K
AGE
50
TENURE
0.8 yrs

Devin Binford

TITLE
Independent Director
TENURE
0.8 yrs

Melvin Yellin

TITLE
Independent Director
AGE
77
TENURE
0.8 yrs

Stephen Graham

TITLE
Independent Director
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • Dixie Brands individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
18. Jul 19 Sell Vincent Keber Individual 16. Jul 19 16. Jul 19 -1,740,836 $0.45 $-787,563
X
Management checks
We assess Dixie Brands's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Dixie Brands has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

DIXI.U News

Simply Wall St News

DIXI.U Company Info

Description

Dixie Brands Inc., through its subsidiaries, provides marijuana infused products. The company offers cannabis products, such as elixirs, chocolates, synergies, dew drops, gummies, mints and tarts, bursts, topical products, and tablets. It also designs and distributes packaging, ingredients, and non-cannabis consumer goods, as well as consulting services for marijuana infused products. The company has a strategic partnership with AriZona Beverages USA LLC for the production, distribution, and sale of cannabis-infused products containing tetrahydrocannabinol. Dixie Brands Inc. is headquartered in Denver, Colorado.

Details
Name: Dixie Brands Inc.
DIXI.U
Exchange: CNSX
Founded:
$70,453,331
125,809,521
Website: http://www.dixieelixirs.com
Address: Dixie Brands Inc.
4990 Oakland Street,
Denver,
Colorado, 80239,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX DIXI.U Subordinate Voting Shares Canadian National Stock Exchange CA USD 30. Nov 2018
OTCPK DXBR.F Subordinate Voting Shares Pink Sheets LLC US USD 30. Nov 2018
DB 0QV Subordinate Voting Shares Deutsche Boerse AG DE EUR 30. Nov 2018
Number of employees
Current staff
Staff numbers
35
Dixie Brands employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:49
End of day share price update: 2019/09/20 00:00
Last earnings filing: 2019/08/29
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.